• SUSTAIN FORTE: 2-mg Semaglutide Bests 1 mg in Type 2 Diabetes

    2 monthes ago - By Medscape

    Accumulating evidence shows that for many patients with type 2 diabetes the 2-mg dose of the GLP-1 agonist semaglutide is better than 1 mg if the goal is a larger drop in A1c and weight
    Medscape Medical News
    Read more ...

     

  • ADA Guidance: Bring Type 1 Diabetes in Adults Out of the Shadows

    2 monthes ago - By Medscape

    The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an emphasis on psychosocial issues. Feedback is welcome until July 8.
    Medscape Medical News
    Read more ...

     

  • Pramlintide-insulin co-formulation improves time in range in type 1 diabetes

    Pramlintide-insulin co-formulation improves time in range in type 1 diabetes

    2 monthes ago - By Healio

    ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter.
    “ADO09 is a new and innovative co-formulation of two hormones missing in type 1 diabetes: insulin and its little sister amylin, co-secreted by the pancreas with insulin,” Gregory Meiffren, PhD, director of clinical development, PKPD and biology at Adocia, told Healio. “When we compared the effect of ADO09 to that of insulin aspart, one of the
    Read more ...